TYK Medicines, Inc

SEHK:2410 Stock Report

Market Cap: HK$20.6b

TYK Medicines Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Yusheng Wu

Chief executive officer

CN¥2.9m

Total compensation

CEO salary percentage82.0%
CEO tenure7.1yrs
CEO ownershipn/a
Management average tenure5.4yrs
Board average tenure1.7yrs

Recent management updates

No updates

Recent updates

CEO Compensation Analysis

How has Yusheng Wu's remuneration changed compared to TYK Medicines's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2024n/an/a

-CN¥428m

Mar 31 2024n/an/a

-CN¥407m

Dec 31 2023CN¥3mCN¥2m

-CN¥382m

Dec 31 2022CN¥2mCN¥2m

-CN¥311m

Compensation vs Market: Yusheng's total compensation ($USD394.20K) is about average for companies of similar size in the Hong Kong market ($USD471.06K).

Compensation vs Earnings: Yusheng's compensation has increased whilst the company is unprofitable.

CEO

Yusheng Wu (60 yo)

7.1yrs

Tenure

CN¥2,877,000

Compensation

Dr. Yusheng Wu, Ph.D. is Executive Chairman of TYK Medicines, Inc. and serves as its Director and Chief Executive Officer since November 2, 2017 and was re-designated as an executive Director on January 17...

Leadership Team

NamePositionTenureCompensationOwnership
Yusheng Wu
Founder7.1yrsCN¥2.88mno data
Jun Li
Co-Founder & Non-Executive Directorno dataCN¥902.00kno data
Shaoqing Chen
Senior Vice President of Medicinal Chemistry Department3.6yrsno datano data
Xiugui Chen
Senior Vice President of Clinical & Registration Department6.3yrsno datano data
Mingyu Jiang
Joint Company Secretary5.4yrsno datano data
Wing Yee Wong
Joint Company Secretaryless than a yearno datano data

5.4yrs

Average Tenure

58yo

Average Age

Experienced Management: 2410's management team is seasoned and experienced (5.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Yusheng Wu
Founder7.1yrsCN¥2.88mno data
Jun Li
Co-Founder & Non-Executive Director3.9yrsCN¥902.00kno data
Mingyu Jiang
Joint Company Secretaryless than a yearno datano data
Eric Gu
Non-Executive Director7.1yrsno data2.22%
HK$ 457.9m
Senquan Zhang
Independent Non- Executive Directorless than a yearno datano data
Xiaoying Meng
Non-Executive Director3.9yrsno datano data
Chao He
Non- Executive Director2.5yrsno datano data
Zhao Ding
Non- Executive Directorless than a yearno datano data
Wenqing Xu
Independent Non- Executive Directorless than a yearno datano data
Xiuhua Shen
Independent Non- Executive Directorless than a yearno datano data
Yuting Leng
Independent Non- Executive Directorless than a yearno datano data
Chengshan Niu
Chairperson of the Supervisory Board & Senior Dir. of Medicinal Chemistry Dept.6.6yrsno datano data

1.7yrs

Average Tenure

45.5yo

Average Age

Experienced Board: 2410's board of directors are not considered experienced ( 1.7 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 16:30
End of Day Share Price 2024/12/24 00:00
Earnings2024/06/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

TYK Medicines, Inc is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution